E-LIB Suche - Ergebnisse für: Pouli, A

1

PRIMARY BREAST LYMPHOMA: PATIENT CHARACTERISTICS, TREATMENT..:

Bampali, V. ; Sioni, A. ; Arapaki, M....
Hematological Oncology. 41 (2023) S2 - p. 701-701 , 2023

Link: https://doi.org/10.1002/..

2

Effect of 1st line treatment on aortic inflammation as asse..:

Solomou, E ; Terentes-Printzios, D ; Kafouris, P...
European Heart Journal. 43 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

3

P916: COEXISTENCE OF ≥2 HIGH-RISK MOLECULAR ABNORMALITIES S..:

Katodritou, E. ; Dalampira, D. ; Triantafyllou, T....
HemaSphere. 6 (2022) - p. 806-807 , 2022

Link: https://doi.org/10.1097/..

4

Arterial stiffness improves with effective chemotherapy in ..:

Solomou, E ; Ioakimidis, N ; Terentes-Printzios, D...
European Heart Journal. 42 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

5

Association of arterial inflammation as assessed by 18FDG-P..:

Solomou, E ; Ioakimidis, N ; Terentes-Printzios, D...
European Heart Journal. 42 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

6

A proposed index of diffuse bone marrow [18F]-FDG uptake an..:

Paschali, A. ; Panagiotidis, E. ; Triantafyllou, T....
European Journal of Nuclear Medicine and Molecular Imaging. 48 (2020) 5 - p. 1487-1497 , 2020

Link: https://doi.org/10.1007/..

7

The effects of chemotherapy on arterial inflammation assess..:

Solomou, E ; Koutagiar, I ; Ioakimidis, N...
European Heart Journal. 41 (2020) Supplement_2 - p. , 2020

Link: https://doi.org/10.1093/..

8

Severity and type of lymphoma are associated with aortic 18..:

Koutagiar, I ; Georgakopoulos, A ; Pouli, A...
European Heart Journal. 41 (2020) Supplement_2 - p. , 2020

Link: https://doi.org/10.1093/..

9

P3363Severity of lymphoma is associated with aortic FDG upt..:

Solomou, E ; Koutagiar, I ; Vlachopoulos, C...
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019

Link: https://doi.org/10.1093/..

10

PCN78 - EVALUATING THE ECONOMIC CONSEQUENCES OF NOVEL AGENT..:

Siskou, O. ; Vasilakopoulos, T. ; Galanis, P....
Value in Health. 21 (2018) - p. S27 , 2018

Link: https://doi.org/10.1016/..

11

PCN113 - EVALUATING THE ECONOMIC IMPACT OF NOVEL AGENTS FOR..:

Siskou, O. ; Terpos, E. ; Galanis, P....
Value in Health. 21 (2018) - p. S33 , 2018

Link: https://doi.org/10.1016/..

12

The Management and Costs of Multiple Myeloma in Greece: Map..:

Siskou, O ; Kaitelidou, D ; Delimpasi, S...
Value in Health. 19 (2016) 7 - p. A609 , 2016

Link: https://doi.org/10.1016/..

13

Budget Impact Analysis of Panobinostat – Bortezomib and Dex..:

Vellopoulou, K ; Kourlaba, G ; Delimpasi, S...
Value in Health. 19 (2016) 7 - p. A729 , 2016

Link: https://doi.org/10.1016/..

14

A433 Comparison of Serum Cytokines with Prognostic Impact i..:

Maltezas, D ; Tzenou, T ; Vassilakopoulos, TP...
Clinical Lymphoma and Myeloma. 9 (2009) - p. S69 , 2009

Link: https://doi.org/10.1016/..

15

A425 EGFR Based on Cystatin-C, Creatinine, and Age Is Indep..:

Dimopoulos, MA ; Kastritis, E ; Katodritou, E...
Clinical Lymphoma and Myeloma. 9 (2009) - p. S68 , 2009

Link: https://doi.org/10.1016/..